News
Biotech Booster 2027 opening soon
After three successful project rounds, the 2027 Biotech Booster round will soon open for pre-applications. For each round, funding is available up to €200.000 for Level 1 projects and €1.9 million for Level 2 projects.
inSteps receives funding from Innovatiefonds Noord-Holland for the development of an AI-driven computer simulation platform for thrombectomy.
inSteps B.V., a spin-out of Amsterdam UMC, has received a convertible loan of €450,000 from the Innovatiefonds Noord-Holland. With this funding, the company will further develop its AI-driven computer simulation platform for thrombectomy.
TargED Announces First Patients Successfully Dosed in Study of TGD001 in Acute Ischemic Stroke
TargED Biopharmaceuticals B.V., a clinical-stage biotechnology company developing next-generation targeted treatments for thrombotic diseases, today announced that the first patients have been dosed in a Phase 1b/2a proof-of-concept clinical study evaluatin
Eliminating cancer with light: KWF invests €4 million in first patient study Lumox
Killing cancer cells with light. Does that sound like science fiction? It's not. In fact, KWF Kankerbestrijding has been supporting scientific research at Utrecht University for years to bring this treatment to people.
We're hiring: Communication Coordinator for LifeSciences@Work
Are you passionate about science communication and eager to help innovative life sciences startups grow their impact? LifeSciences@Work is looking for a Communication Coordinator to strengthen our team.
TargED Raises €40.4M Series A2 to Advance First-in-Class Targeted Thrombolytic TGD001
Utrecht, the Netherlands, June 24, 2026 – TargED Biopharmaceuticals B.V., a clinical-stage biotechnology company developing next-generation targeted treatments for thrombotic diseases, today announced the second and final closing of its Ser
Cohort 2 BioVenture Builder: Selection process started
Many early‑stage biotech founders get stuck between preclinical validation and investor readiness.
Rotterdam Square launches NL USA Health Accelerator in collaboration with Cedars-Sinai Accelerator+ and Erasmus MC
Rotterdam Square is pleased to announce the launch of the NL USA Health Accelerator, a new international initiative developed in collaboration with Cedars-Sinai Accelerator+ and Erasmus MC, to be unveiled at the leading healthcare innovation event, HLTH Europe.
Lumox wins Health & Wellbeing category at the NL Startup Competition
Lumox, alumnus of the Venture Challenge, has been named the winner of the Health & Wellbeing category at the NL Startup Competition 2026.
These are the Venture Challenge Spring 2026 teams!
Six teams have started the Venture Challenge Spring edition 2026! These starting life sciences entrepreneurs will learn everything about building and pitching a business plan.